tiprankstipranks
American Healthcare REIT, Inc. (AHR)
NYSE:AHR
US Market
Want to see AHR full AI Analyst Report?

American Healthcare REIT, Inc. (AHR) Earnings Dates, Call Summary & Reports

236 Followers

Earnings Data

Report Date
Aug 12, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.15
Last Year’s EPS
0.06
Same Quarter Last Year
Based on 9 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 07, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized strong operating and financial momentum driven by double-digit same-store NOI growth, robust acquisition activity, an awarded pipeline, improved leverage and liquidity, and raised guidance—balanced with noted conservatism around SHOP pacing, slower growth in outpatient/triple-net segments, regulatory reimbursement headwinds (CMS), modest cap-rate tightening, and higher G&A from stock-based comp. Overall, the company conveyed confidence in durable demand, operator execution, and accretive capital deployment while acknowledging near-term operational and market execution risks.
Company Guidance
The company raised full-year 2026 guidance, boosting same-store NOI growth to 9%–12% and raising NFFO per share guidance to about $2.09–$2.30 (roughly 20% growth versus 2025); segment-level 2026 same-store NOI guidance was set at 11%–15% for Trilogy (Q1 Trilogy same-store NOI was 14.5% with 91.2% occupancy), 15%–19% for SHOP (Q1 SHOP same-store NOI was 19.7% with 88.6% occupancy), 0%–2% for outpatient medical, and 2%–3% for triple-net leases. Supporting quarter-to-date metrics include Q1 NFFO of $0.50 per diluted share (up 31.6% YoY from $0.38), total-portfolio Q1 same-store NOI of 12.1%, net debt/annualized EBITDA improved to 3.0x from 3.4x, YTD closed acquisitions of $249.2M (including $162.8M in Q1) with ~$650M+ of awarded pipeline expected to close in 2026, in-process development cost of ~$173.9M ( ~$52.4M funded), $950M of 2025 acquisitions now accreting to earnings, ATM forward sale arrangements totaling ~$412.7M (with ~$527.4M unsettled forwards and >$1B capacity available), and an expanded $800M revolver (up from $600M, maturing April 2030) with zero borrowings outstanding.
Sustained Same-Store NOI Growth
Total portfolio same-store NOI grew 12.1% in Q1 2026, marking the ninth consecutive quarter of double-digit same-store NOI growth.
Trilogy (ISHC) Outperformance
Trilogy delivered same-store NOI growth of 14.5% with same-store occupancy averaging 91.2% (up ~220 bps year-over-year). Same-store revenue grew 6.9% and same-store NOI margins eclipsed 20% (first time since COVID). Quality mix improved to 75.5% of resident days (up ~60 bps YoY).
SHOP Segment Strength
SHOP same-store NOI increased 19.7% with same-store occupancy at 88.6% (up ~255 bps YoY) and same-store NOI margin expanded ~215 bps to 20.6%.
Strong Earnings Growth (NFFO)
Reported normalized funds from operations (NFFO) of $0.50 per diluted share in Q1 2026, a 31.6% increase from $0.38 in Q1 2025.
Raised 2026 Guidance
Raised full-year same-store NOI growth guidance to a range of 9%–12% and increased full-year NFFO per share guidance (midpoint up $0.04) to reflect an expected ~20% NFFO per share growth over 2025. Segment-level same-store NOI guidance: Trilogy 11%–15%, SHOP 15%–19%, outpatient medical 0%–2%, triple-net 2%–3%.
Active, Accretive Acquisition Program
Year-to-date closed acquisitions of $249.2 million (approximately $162.8 million in Q1), subsequent quarter-end closings of ~$86.4 million, and 2025 acquisitions of $950 million contributing to earnings. Management emphasized accretive deployment and selective, operator-first underwriting.
Large Awarded Pipeline
Pipeline of over $650 million in awarded SHOP deals (management expects the majority to close by quarter-end with the remainder in Q3), plus an in-process development pipeline of ~$173.9 million in expected cost (≈$52.4 million funded).
Improved Balance Sheet and Liquidity
Net debt to annualized EBITDA improved to 3.0x as of 03/31/2026 (down from 3.4x at year-end 2025). Increased unsecured revolver capacity from $600 million to $800 million (maturity extended to April 2030) with $0 outstanding, and ATM/forward sale agreements in place representing significant potential gross proceeds (examples: ~8.1 million shares for $412.7 million; unsettled forward agreements representing ~ $527.4 million).

American Healthcare REIT, Inc. (AHR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AHR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 2026
2026 (Q2)
0.15 / -
0.06
May 07, 2026
2026 (Q1)
0.16 / 0.13
-0.04425.00% (+0.17)
Feb 26, 2026
2025 (Q4)
0.15 / 0.06
-0.21128.57% (+0.27)
Nov 06, 2025
2025 (Q3)
0.16 / 0.33
-0.031200.00% (+0.36)
Aug 07, 2025
2025 (Q2)
0.12 / 0.06
0.01500.00% (+0.05)
May 08, 2025
2025 (Q1)
0.05 / -0.04
-0.040.00% (0.00)
Feb 27, 2025
2024 (Q4)
0.08 / -0.21
-0.4250.00% (+0.21)
Nov 12, 2024
2024 (Q3)
>-0.01 / -0.03
-0.0966.67% (+0.06)
Aug 05, 2024
2024 (Q2)
0.00 / 0.01
May 13, 2024
2024 (Q1)
-0.35 / -0.04
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AHR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2026
$49.60$51.71+4.25%
Feb 26, 2026
$52.91$51.96-1.79%
Nov 06, 2025
$47.41$48.90+3.13%
Aug 07, 2025
$39.20$39.84+1.63%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does American Healthcare REIT, Inc. (AHR) report earnings?
American Healthcare REIT, Inc. (AHR) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
    What is American Healthcare REIT, Inc. (AHR) earnings time?
    American Healthcare REIT, Inc. (AHR) earnings time is at Aug 12, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AHR EPS forecast?
          AHR EPS forecast for the fiscal quarter 2026 (Q2) is 0.15.